OrbusNeich Medical Group Holdings Limited

Equities

6929

KYG6773B1005

Medical Equipment, Supplies & Distribution

Market Closed - Hong Kong S.E. 04:08:20 2024-04-26 am EDT 5-day change 1st Jan Change
3.83 HKD +4.08% Intraday chart for OrbusNeich Medical Group Holdings Limited +6.09% -45.67%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
OrbusNeich Medical Group’s Profit Up 144% in 2023 MT
OrbusNeich Medical Group Holdings Limited Proposes Final Dividend for the Year Ended December 31, 2023, Payable on 28 June 2024 CI
OrbusNeich Medical Group Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2023 CI
OrbusNeich Medical Seeks M&A Opportunities CI
OrbusNeich Medical Group Holdings Limited acquired SJ Medicare Co. Ltd. CI
OrbusNeich Expects More Than Doubling of 2023 Profit MT
Certain Ordinary Shares of OrbusNeich Medical Group Holdings Limited are subject to a Lock-Up Agreement Ending on 22-DEC-2023. CI
OrbusNeich Medical Subsidiary Buys 84% Stake in Indonesian Medical Device Maker MT
OrbusNeich Medical to Acquire Eucatech for 2.4 Million Euros MT
OrbusNeich Medical Group Holdings Limited acquired Eucatech AG for ?2.4 million. CI
OrbusNeich Medical Extends Term of Exclusive US Distributor of Products to 2027 MT
Orbusneich Medical Group Holdings Limited and Cardiovascular Systems, Inc. Enters into an Amendment to Distribution Agreement CI
OrbusNeich Medical Group Holdings Limited(SEHK:6929) added to S&P Global BMI Index CI
OrbusNeich Medical Group Holdings Limited Announces Retirement of Ching Chung John Chow from the Group of All Executive Roles and Has Been Re-Designated as Non-Executive Director with effect from September 7, 2023 CI
OrbusNeich Medical Group Holdings Limited Reports Earnings Results for the Half Year Ended June 30, 2023 CI
OrbusNeich to Log 200% Boost in H1 Profit MT
OrbusNeich Medical Group Holdings Limited Provides Earnings Guidance for the Six Months Ended June 30, 2023 CI
Certain Ordinary Shares of OrbusNeich Medical Group Holdings Limited are subject to a Lock-Up Agreement Ending on 22-JUN-2023. CI
OrbusNeich Medical Group Holdings Limited Appoints Ting San Peter Lionel LEUNG as Non-Executive Director CI
OrbusNeich Medical to Set Up R&D, Production Base for 300 Million Yuan MT
OrbusNeich Medical Group Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2022 CI
China's Rising COVID Infections Breaks Hong Kong Stocks' Two-Day Gaining Spell; Fifth SPAC Untraded, Two Firms Gain in Debut MT
OrbusNeich Debuts Flat in Hong Kong MT
OrbusNeich Medical Group Holdings Limited has completed an IPO in the amount of HKD 480.7704 million. CI
OrbusNeich Raises HK$367 Million in Hong Kong IPO MT
Chart OrbusNeich Medical Group Holdings Limited
More charts
OrbusNeich Medical Group Holdings Ltd is an investment holding company principally engaged in the development, production and sales of medical equipment and machineries. The Company is engaged in the design, development, manufacture, distribution and sale of interventional medical devices for the treatment of coronary heart disease and peripheral vascular diseases. The Company's main products include percutaneous coronary intervention (PCI) and percutaneous transluminal angioplasty (PTA) balloons. In addition, the Company's products also include semi-compliant balloons and scoring balloons for pre-dilatation and lesion preparation, coronary stents for implantation, non-compliant balloons for post-dilatation and specialty catheters. The Company mainly conducts its businesses in domestic and overseas markets.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
3.545 CNY
Average target price
6.393 CNY
Spread / Average Target
+80.33%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. 6929 Stock
  4. News OrbusNeich Medical Group Holdings Limited
  5. OrbusNeich Expects More Than Doubling of 2023 Profit